Significantly more adolescent patients receiving baricitinib had hair regrowth compared with patients receiving placebo.

The BRAVE-AA-PEDS trial found that once-daily baricitinib significantly improved hair regrowth on the scalp, eyebrows, and eyelashes in adolescents with severe alopecia areata after 36 weeks, with ...

For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study presented at the annual meeting of the American Academy of Dermatology, held ...

Please provide your email address to receive an email when new articles are posted on . Patients with severe to very severe alopecia areata saw hair regrowth with bempikibart treatment within 24 ...

Bempikibart is a novel IL-7/thymic stromal lymphopoietin (TSLP) inhibitor that was associated with clinically meaningful and durable responses in patients with severe or very severe alopecia areata ...

Louis Theroux has revealed he is preparing for a "full head shave" due to his battle with alopecia. The broadcaster, 54, said ...

At week 36, 42.4 and 27.4% of patients receiving baricitinib 4mg and baricitinib 2mg, respectively, achieved a SALT score of less than or equal to 20 compared with 4.5% of patients receiving placebo.

At week 36 of the trial, there was significant regrowth of eyebrows and eyelashes with patients taking 4 mg of baricitinib compared with placebo. HealthDay News — For adolescents with severe alopecia ...

TUESDAY, March 18, 2025 (HealthDay News) -- For adolescents with severe alopecia areata (AA), baricitinib is efficacious for ...

TUESDAY, March 18, 2025 (HealthDay News) -- For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study presented at the annual meeting of the ...